Aplex Bio - Solna, Sweden

APLEX Bio is an innovative Swedish start-up that was established in 2020. Its cutting-edge hyperplexed molecular detection technology enables the analysis of a large number of biomarkers both in-vitro and in-situ. This technology can be used for a range of applications, from research to mass-scale in-vitro diagnostics (IVD) and precision diagnostics. APLEX Bio is based in Stockholm at the Karolinska Institute (KI) campus, and is a part of KI Innovations.